Fri, Aug 29, 2014, 2:15 PM EDT - U.S. Markets close in 1 hr 45 mins

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • encore7 encore7 Jul 14, 2013 12:36 AM Flag

    CG's optimism on stock price at JMP 2013 Securities Conference

    Looks like CG is also expecting a big spike in stock price, no? Look at the following quote from the JMP Securities Conference:

    "It gives us really just some flexibility of continuing to advance the company moving forward. It's just a tool in the financing tool box, we're not guiding on if, when, how we will deploy this, but it gives us that opportunity. We have high volume, stock, it can be volatile at times. And so this really allows us to take advantage of issuing the least amount of shares at the highest price as possible when we see it fit."

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Lots to like about that quote. My key takeaway was his reinforcement to institutional backers: yes, we dilute to raise much needed cash, but we will be neither greedy nor imprudent about the way will do it. And the (relatively) nominal amount we will raise will carry us through to revenue generation. Very high marks to CG for benchmarking bvia dollars (125MM) rather than # of shares.

      (And despite the ad nauseum discussions here on shorting, I do have a question. Assuming AA exhausts shares available for purchase, and market makers demand that shorts cover, what timeframe is involved? Must they cover immediately, within X trading days, what? And is $TSLA a realistic model for what we may witness (and experience) in the coming days? Many thanks for responses from people who have traveled this road.)

      Sentiment: Strong Buy

      • 2 Replies to general_galland
      • The tipical case when you absolutely have to deliver the shares (and thus cover the shares shorted) is the case of a takeover. Otherwise you can remain "short" but have to adjust your margins according to your losses. Margin requirements may also change, another risk factor. It really depends on longs now, though, to resist the temptation to sell. Shorts are short of ammunition.

      • cg is expecting a spike from accelerated approval and he wanted the funding mechanism in place to take advantage of it

        he blew it last time; stock spiked in the 40's on trial results yet he waited until $25 to issued secondary

        he's not going to make that mistake again

        if/when the stock spikes like it did last oct, all he has to do is hit the sell button

        pretty clear sign he expects aa and he expects a pretty big spike to come out of it and he's going to take advantage

        Sentiment: Strong Buy

    • I remember taking note of that statement, too. Totally agree.

      Sentiment: Strong Buy

 
SRPT
22.56+0.43(+1.94%)2:14 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.